BofA analyst Matthew DeYoe lowered the firm’s price target on Westlake (WLK) to $104 from $119 and keeps a Neutral rating on the shares. Investors were growing increasingly concerned about the Q1 print, though “the headline still managed to disappoint,” says the analyst, who adds that the “confidence interval is lower” following the Q1 miss and the sequential starting point to profits is also lower.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Westlake: Neutral Rating Reaffirmed as Q1 Miss Tempers Near-Term Outlook; $125 Price Target Maintained
- Westlake Chemical Balances Q1 Setbacks With Recovery Momentum
- Westlake price target raised to $115 from $80 at Morgan Stanley
- Westlake Posts Q1 2026 Loss Amid Restructuring Efforts
- Westlake reports Q1 EPS (77c), consensus (24c)
